1. Home
  2. FTRE

FTRE

Fortrea Holdings Inc.

Logo Fortrea Holdings Inc.

Health Care

Medical Specialities

Nasdaq

as 04-17-2024 3:31pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Founded: 1996 Country:
United States
United States
Employees: N/A City: DURHAM
Market Cap: 3.5B IPO Year: N/A
Target Price: $38.14 AVG Volume (30 days): 809.4K
Analyst Decision: Buy Number of Analysts: 8
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.04 EPS Growth: N/A
52 Week Low/High: $24.93 - $41.02 Next Earning Date: 05-07-2024
Revenue: $3,109,000,000 Revenue Growth: 0.42%
Revenue Growth (this year): 1.29% Revenue Growth (next year): 3.11%

Share on Social Networks: